Tag:
Merck
Latest Headlines
Latest Headlines
New study confirms worst fears about Merck's HIV vaccine
Five years ago Merck investigators stunned everyone working in the AIDS research field with the news that they were abruptly halting a study of a prospective HIV vaccine after the data began to make clear that it wasn't only failing to guard against the virus, but appeared to increase the risk of becoming infected.
CDC delivers gift to hep C drugmakers
The recommendation by the CDC that the 70 million U.S. baby boomers all be tested for hepatitis C is a big gift for the newest hep C treatments.
UPDATED: New cloud hovers over class of 'good cholesterol' drugs
Fresh doubts have cropped up for raising "good cholesterol" to combat heart attack risk, after a new study showed that patients genetically programmed to have higher levels of HDL cholesterol didn't appear to be more protected from heart disease than those with low levels.
Merck notches a win in Vioxx litigation
Merck won a legal victory in Australia in its ongoing litigation over painkiller Vioxx outside of the U.S.
FDA review questions long-term use of bone-building drugs
The FDA is giving women a lot to chew on with a new analysis of long-term use of drugs for osteoporosis because they can, although rarely, have a debilitating effect.
Study: Further insight into Merck HIV vax infection increase
A recent study published in the Journal of Infectious Disease confirmed that a vaccine study halted in 2007 showed an increased risk of infection in the first 18 months for subgroups of the men who were vaccinated, but that this difference disappeared after 18 months.
Roche gives up on anticipated 'good cholesterol' drug
Roche's once-promising "good cholesterol" drug candidate is now history.
Roche abandons potential blockbuster cholesterol drug
The Swiss drug giant's failure brings negative attention to similar drugs in development at Merck and Eli Lilly that raise "good" cholesterol to combat cardiovascular disease.
Software provider to Merck taps IBM cloud to fight fake drugs
Cambridge, MA-based Sproxil, which provides tech to combat drug counterfeiting to Merck and GlaxoSmithKline, says the company has harnessed IBM's cloud computing and visualization software to improve its product.
Merck expands packaging plant to take on more vaccines
With increased production and growing supplies, the company hopes to regain some of the momentum with Zostavax that was lost when production issues derailed plans in 2006.
